Skip to content

Clinical trials

Phase 1 Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 1 Country / region: United States Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20026
20034
20043
20057
20064
20074
20084
20092
20104
20111
20121
20132
20161
20171
20181
20194
20206
20213
20226
20234
20245
20251
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Recruiting15
Terminated15
Active, not recruiting9
Withdrawn3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins10
Incyte Corporation5
Memorial Sloan Kettering Cancer Center5
Fred Hutchinson Cancer Center4
M.D. Anderson Cancer Center4
Northwestern University4
Dana-Farber Cancer Institute3
University of Chicago3
California Cancer Consortium2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders106
Leukemia, Myeloid, Acute69
Myelodysplastic Syndromes62
Precursor Cell Lymphoblastic Leukemia-Lymphoma57
Leukemia, Myelomonocytic, Chronic55
Primary Myelofibrosis51
Leukemia48
Leukemia, Lymphocytic, Chronic, B-Cell46
Lymphoma, Non-Hodgkin37
Multiple Myeloma36

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.